Changes in Causes of Death and Associated Conditions Among Persons with HIV/AIDS After the Introduction of Highly Active Antiretroviral Therapy in Taiwan  by Lu, Tsung-Hsueh et al.
604 J Formos Med Assoc | 2006 • Vol 105 • No 7
BRIEF COMMUNICATION
Highly active antiretroviral therapy (HAART) and
better prophylaxis of opportunistic infections have
improved survival and quality of life among indi-
viduals with human immunodeficiency virus (HIV)
infection and acquired immunodeficiency syn-
drome (AIDS). Studies attempting to define trends
in causes of death and associated conditions since
the introduction of HAART have yielded inconsis-
tent results, especially for deaths related to liver dis-
ease and non-AIDS-related malignancy.1–9 Most of
the studies to date have been hospital-based and
have been limited by poor reliability in assigning
the underlying cause of death (UCD).1–7 In this
study, we cross-linked national HIV registry data
with cause-of-death data to investigate changes in
UCD and associated conditions among HIV/AIDS
patients after the introduction of HAART in Taiwan.
Methods
Linking three datasets
This investigation was part of a collaborative
fproject initiated by the Taiwan Department o
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Health to evaluate healthcare utilization and 
effects of HAART. The following three datasets
were linked in this study: the National HIV/
AIDS Registry, National Health Insurance of
Taiwan (NHI) claims data, and national cause-
of-death data.
The National HIV/AIDS Registry was created in
1984 and is managed by the Taiwan Center for
Disease Control (CDC); reporting of HIV/AIDS
cases to the government is mandatory. The registry
collects information on the results of HIV tests and
HIV exposure category as well as demographic and
identification data. For this study, we included
data compiled from 1994 to December 2002.
National cause-of-death data, which are man-
aged by the Office of Statistics, Department of
Health, have been available in electronic form since
1971. The present study used cause-of-death data
from the period January 1994–December 2002.
NHI claims data were used to identify associ-
ated conditions and to assess the validity of UCD
assignments. The NHI program, implemented in
March 1994, covers almost every Taiwan resident.
The NHI program also covers HAART expendi-
tures for all HIV/AIDS patients. Claims data in-
clude three diagnoses for each ambulatory visit
and five diagnoses for each hospitalization. In
most clinics and hospitals, physicians personally
report the International Classification of Diseases,
9th Revision, Clinical Modification (ICD-9-CM)
codes of the three diagnoses for each ambulatory
visit. For inpatients, licensed professional coders
are in charge of coding one main diagnosis and
four sub-diagnoses for each hospitalization after
reviewing the medical records. The NHI Bureau
regularly samples the medical records from hospi-
tals to evaluate the accuracy of discharge diag-
noses coding in claims data. For this study, only
NHI claims data for the period January 1998–
December 2002 were available for analysis.
Every citizen has an identification number in
Taiwan, which was used as the key variable in
linking the three datasets. After linkage of the
three datasets by the information center, the
identification number was scrambled to protect
the privacy of the patients; investigators could
gnot link personal data with the correspondin
individual.
Grouping the UCD and associated conditions
We grouped the UCD into the following cate-
gories: HIV/AIDS (ICD-9 codes 042–044, 279);
tuberculosis and mycosis (ICD-9 codes 010–018,
110–118); other infectious diseases; cancer (ICD-9
codes 140–208); circulatory diseases (ICD-9 codes
390–459); pneumonia (ICD-9 codes 480–487);
liver disease (ICD-9 codes 070, 570–573); uninten-
tional injury (ICD-9 codes E800–E928); suicide
(ICD-9 codes E950–E958); and others.
fBecause certifiers might have omitted some o
the associated conditions from the death certifi-
cates, we analyzed all diagnoses listed in the
hospitalizations within 30 days before death to
obtain a more complete picture of associated
fconditions. We did not include the diagnoses o
ambulatory visits because the diagnoses and
tICD-9 codes given by the physicians could no
be verified. The categories and ICD-9 codes used
for comparison were based on Selik et al.9
To adjust for possible artifacts due to incor-
rect death certification, we used the discharge
diagnoses from the last hospitalization before
death (obtained from NHI claims data) to re-
assess whether the death was due to HIV/AIDS-
related causes. Two authors reassigned the UCD
according to the criteria proposed by Johansson
and Westerling.10 tIn 12 (4%) cases, a differen
UCD was initially assigned by the two reviewers
and a consensus was reached after discussion.
Analyzing trends in cause of death
We first examined the proportion of deaths in
which HIV/AIDS was not the UCD by year, ac-
cording to the original cause-of-death data. The
proportions according to reassigned data were
available for the period 1998–2002 only. To
assess the changes in distribution of the causes
of death, we categorized the year of death as
1994–1996 (pre-HAART period), 1997–1999
(early HAART period), and 2000–2002 (late
HAART period). For associated conditions, we
separated the study period into 1998–2000 and
f fCauses o  death a ter HAART in Taiwan
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2001–2002. Changes in the proportion of each
disease category by period were examined by
Fisher’s exact test or χ2 test.
Results
Seven hundred and fifty-two people listed in the
National HIV/AIDS Registry died during the study
period (1994–2002). Of the 462 linked patients
who died during the period 1998–2002, 312
(67.5%) could be further linked to the NHI claims
dataset based on hospitalization records within
30 days of death.
Changes in UCD distribution from the early
HAART (1994–1996) to the late HAART (2000–
2002) periods are shown in Table 1. HIV/AIDS
remained the leading cause of death among per-
sons reported with HIV/AIDS throughout the
study period, followed by cancer, suicide, and
liver disease. However, the proportion of deaths
with HIV/AIDS as the UCD decreased 20%, from
79% in the early HAART to 64% in the late
HAART period. Using reassigned UCD data did
not affect this pattern. In 2002, more than 40%
of the deaths had an original UCD that was not
HIV/AIDS.
The UCD with the greatest increase during
the study period was suicide (p = 0.035), from 
three (1.5% of total) in the pre-HAART period
to 14 (4.8%) in the late HAART period. Infec-
tious diseases, cancer, and liver disease also ac-
 counted for increasing proportions of deaths,
although these increases did not reach signifi-
cance (Table 1).
 Changes in the frequencies of conditions
associated with death between the early and late
HAART periods are shown in Table 2. Most AIDS-
related conditions recorded at death decreased in
frequency, although these changes were not sig-
nificant. Non-Hodgkin’s lymphoma increased in
frequency (p<0.05), as did candidiasis and tuber-
culosis, although changes in the latter two were
not statistically significant. Non-AIDS-related con-
ditions that increased in frequency included sep-
ticemia, kidney disease, viral hepatitis, anemia,
and acute respiratory distress syndrome. Again,
these changes were not statistically significant.
Discussion
One of the strengths of this study was that the
rNHI program covers HAART expenditures fo
tevery HIV/AIDS patient, which is likely to resul
in a fairly complete registration of patients in the
dataset. Our findings indicate that non-HIV/AIDS
gcauses have been responsible for an increasin
Table 1. Changes in the distribution of underlying cause of death (UCD) among persons with HIV/AIDS, Taiwan 1994–2002
n (%)
UCD ICD-9 codes
1994–1996 1997–1999 2000–2002 Total
HIV/AIDS*† 042, 279 161 (79.3) 203 (79.6) 188 (63.9) 552 (73.4)
Tuberculosis and mycosis 010–018, 110–118 3 (1.5) 3 (1.2) 8 (2.7) 14 (1.9)
Other infectious diseases*‡ – 5 (2.5) 3 (1.2) 13 (4.4) 21 (2.8)
Cancer 140–208 7 (3.4) 10 (3.9) 16 (5.4) 33 (4.4)
Circulatory disease 390–459 3 (1.5) 5 (2.0) 7 (2.4) 15 (2.0) 
Pneumonia 480–487 7 (3.4) 5 (2.0) 7 (2.4) 19 (2.5) 
Liver disease 070, 570–573 3 (1.5) 5 (2.0) 11 (3.7) 19 (2.5)
Unintentional injury E800–E928 2 (1.0) 8 (3.1) 7 (2.4) 17 (2.3)
Suicide§ E950–E958 3 (1.5) 4 (1.6) 14 (4.8) 21 (2.8) 
Others*|| – 9 (4.4) 9 (3.5) 23 (7.8) 41 (5.5) 
Total – 203 (100.0) 255 (100.0) 294 (100.0) 752 (100.0) 
*p < 0.1 based on x2 test; †ICD-9 code 279 was used for the year 1994; ‡ICD-9 codes 038, 041, 079, 084, 136, 320, 322, 324, 599; §p < 0.05 based on x2 test;
||ICD-9 codes 239, 250, 263, 282, 284, 286, 332, 348, 491, 493, 504, 507, 516, 537, 564, 569, 577, 584, 585, 790, 798, 799, E968, E983, E987.
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proportion of deaths among HIV/AIDS patients
since the introduction of HAART in 1997. The
UCD with the greatest increase during this
period was suicide. Most AIDS-related condi-
tions decreased in frequency from 1998–2000 to
2001–2002. However, non-Hodgkin’s lymphoma
showed a significant increase.
With advances in the treatment and prophylaxis
of opportunistic infections, persons with HIV/
AIDS in Taiwan live longer with less comorbidity.11
These improvements, however, have not been
without consequences. The proportion of suicide
deaths among persons with HIV/AIDS in Taiwan
 increased after the advent of HAART and was
relatively high compared with other countries in
the HAART era.1–9 The pace of this increase is
alarming: from 1.5% in 1994–1996 to 4.8% in
2000–2002. Although lingering discrimination,
lack of reffective counseling programs, or othe
societal factors may have played a role in suicide
Table 2. Changes in the proportions of conditions associated with death among persons with HIV/AIDS, Taiwan 1998–2002
n (%)
Conditions ICD-9 codes
1998–2000 2001–2002
AIDS-related conditions
Pneumocystosis 136.3 42 (23.0) 23 (17.8)
Candidiasis 112 28 (15.3) 24 (18.6)
Tuberculosis 010–018 25 (13.7) 21 (16.3)
Cryptococcosis* 117.5 13 (7.1) 3 (2.3)
Cachexia/wasting 261, 263.9, 783.2, 799.4 11 (6.0) 3 (2.3)
Dementia/encephalopathy 290.1, 294.9, 310.9, 323.9, 331.9, 341.9, 9 (4.9) 4 (3.1)
348.3, 348.9, 349.9, 043.1, 049.8, 049.9
Bacterial pneumonia 481–482 7 (3.8) 4 (3.1)
Cytomegalovirus disease 078.5 5 (2.7) 3 (2.3)
Nontuberculous mycobacteriosis 031 5 (2.7) 2 (1.6)
Non-Hodgkin’s lymphoma† 200.0–200.8, 202.8 4 (2.2) 9 (7.0)
Kaposi’s sarcoma 173 3 (1.6) 0 (0.0)
Non-HIV/AIDS-related conditions
Septicemia/septic shock 038, 003.1, 785.5 58 (31.7) 45 (34.9)
Pneumonia, organism unspecified 485–486 49 (26.8) 30 (23.3)
Liver disease 570–573 24 (13.1) 10 (7.8)
Heart disease* 390–398, 402, 404–427.4, 427.6–429 19 (10.4) 6 (4.7)
Kidney disease 580–593 12 (6.6) 11 (8.5)
Gastrointestinal hemorrhage 578.9 9 (4.9) 5 (3.9)
Viral hepatitis 070 8 (4.4) 12 (9.3)
Anemia, unspecified 285.9 8 (4.4) 8 (6.2)
Acidosis 276.2 8 (4.4) 7 (5.4)
Chronic lower respiratory disease 490–496 8 (4.4) 6 (4.7)
Acute respiratory distress syndrome 518.5 7 (3.8) 8 (6.2)
Diabetes mellitus 250 7 (3.8) 1 (0.8)
Aplastic anemia 284.8, 284.9 5 (2.7) 5 (3.9)
Cerebrovascular disease/stroke 430–438 4 (2.2) 3 (2.3)
Alcohol abuse or dependence 303, 305.0 3 (1.6) 2 (1.6)
Lung cancer 162 2 (1.1) 2 (1.6)
Convulsions 780.3 2 (1.1) 4 (3.1)
Total – 183 (100.0) 129 (100.0)
*p < 0.1 and †p < 0.05 based on Fisher’s exact test.
rates, identifying the cause of this increase was
outside the scope of this study.
The hepatotoxicity of HAART regimens has
been discussed in many reports. Consistent with
two population-based studies,8,9 viral hepatitis ac-
counted for an increasing proportion of deaths
after the introduction of HAART. However, we did
not find an increased proportion of deaths due to
liver disease. One possible explanation is that
physicians did not list drug-induced hepatotoxicity
as one of the discharge diagnoses. Another possi-
bility is that HAART did not induce excess hepato-
toxicity among persons with HIV/AIDS in Taiwan.
In contrast to studies from other countries,1–9
we noted an elevated and increasing proportion
of deaths due to candidiasis and tuberculosis in
Taiwan. Differences in the analytical methods
used may be one explanation. Death certificates
were used as the source of diagnostic data for the
associated conditions in the previous studies. In
this study, however, we used the discharge diag-
noses as the source of this data, which might have
led to the inclusion of more non-fatal diagnoses.
Another possible explanation is that HIV/AIDS
patients in Taiwan have a greater chance of ac-
quiring candidiasis and tuberculosis co-infections
than their counterparts in other countries, which
is compatible with the results of hospital-based
studies in Taiwan.11–13
The current study had several limitations.
First, we did not have detailed clinical informa-
tion such as CD4 count, viral load, or adherence
to HAART regimens for each patient. Moreover,
because of the small number of deaths each year,
further analysis of the distribution of the causes
of death and associated conditions by demo-
graphic and exposure characteristics was not prac-
tical. A third limitation concerns the accuracy of
the causes of death reported on the death certifi-
cates. We could only reassign the UCD for individ-
uals who died in 1998 and beyond because of the
lack of availability of hospitalization information
prior to that time. However, the reassigned UCD
data showed patterns similar to those of the ori-
ginal UCD data, indicating that the initial assign-
ment was satisfactory in most cases.
TIn conclusion, after the introduction of HAAR
fin Taiwan in 1997, an increasing proportion o
deaths among individuals with HIV/AIDS was
due to causes other than HIV/AIDS. As the dura-
tion of survival increased, however, the likelihood
of suicide also increased. More efforts are required
to address the mental health of HIV/AIDS patients
as a part of therapy. Finally, differences in the pat-
terns of UCD and associated conditions between
Taiwan and other countries merit further investi-
fgation. These findings highlight the importance o
surveillance of chronic diseases, treatment-related
morbidity, and psychologic wellbeing among in-
dividuals with HIV/AIDS.
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